Nrf2 (Nfe2l2) Kras, whereas Nrf2 -/-tumors were rarely associated with similar Kras mutations. Overall, our results established that Nrf2 has two roles during carcinogenesis, one of which is preventive during tumor initiation, but a second which promotes malignant progression. These findings establish Nrf2 inhibitors as rational tools to prevent malignant progression in lung cancer, whereas Nrf2 activators are more suited for lung cancer prevention.
Introduction
Nrf2 (Nuclear factor-erythroid derived 2-like 2, Nfe2l2) is a leucine zipper transcription factor and plays an important role in the maintenance of redox balance and cytoprotection against chemical carcinogens (1, 2) . Upon oxidative and electrophilic stress conditions, Nrf2 is released from Keap1 (Kelch-like ECH-associated protein 1)-mediated rapid degradation. Nrf2 is stabilized, accumulated, and translocates to the nucleus, where Nrf2 dimerizes with a small Maf protein (sMaf). Nrf2-sMaf heterodimer binds to a specific DNA sequence, referred to as the antioxidant/electrophile response element (ARE/EpRE), and induces the expression of a cohort of cytoprotective enzyme genes, such as Nqo1, HO-1, Gclc and Gstp1/p2 (1, 2) .
Previous reports on chemically induced carcinogenesis have demonstrated that
Nrf2-deficient (Nrf2 -/-) mice tend to form a larger number of tumors than wild-type (Nrf2 +/+ ) mice, indicating that the perturbation in the carcinogen detoxification system in Nrf2 -/--mice leads to cancer susceptibility in various tissues (3) (4) (5) (6) . However, recent studies have revealed that the NRF2 protein is significantly accumulated in many types of human cancers through several independent mechanisms. For instance, somatic mutations in the interface of KEAP1 and NRF2 (7) or epigenetic modifications in the promoter region of KEAP1 genes (8) gives rise to the accumulation of NRF2. As these changes are often related to accelerated cancer cell growth and poor clinical prognosis, the oncogenic side of NRF2 function has been attracting considerable attention. Furthermore, we recently demonstrated that the Nrf2 -/--mice transplanted with Lewis lung carcinoma (3LL) cells provide a more tumor-permissive immune microenvironment than did the Nrf2 +/+ -mice (9) . These observations raise a fundamental question of whether Nrf2 exerts cancer-preventive or -promotive activity in each stage of the carcinogenic process. To address this issue, we employed the urethane (ethyl carbamate)-induced lung carcinogenesis model, a well-known multi-step murine carcinogenesis model (10) . 
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Urethane has been extensively used as an inducer of chemical lung carcinogenesis (11) .
Administration of urethane evokes hyperplasia or adenoma formation in the lung and eventually leads to adenocarcinomas in a time-dependent manner (10) . Through cytochrome P450 2E1 (Cyp2e1)-mediated oxidation, urethane is converted to vinyl carbamate epoxide, which serves as an ultimate carcinogen by inducing DNA-, RNA-, or protein-adduct formation in airway epithelial cells (12) . In the detoxification process, microsomal epoxide hydrolase (mEH) converts vinyl carbamate epoxide into 1,2-dihydroxyethyl carbamate, which subsequently undergoes the glutathione conjugation catalyzed by Gstp1/p2 (13) and is excreted into urine (14) .
In the present study, we found that Nrf2 -/--mutant mice developed a large number of urethane-induced lung micro-nodules in the early phase after the urethane-administration.
However, in the later stages Nrf2 +/+ -mice developed a higher number of Kras-mutated adenocarcinomas than did Nrf2 -/--mice. These results demonstrate that Nrf2-deficiency leads to an increased susceptibility to chemical carcinogens and resultant high-level tumor initiations, while Nrf2 serves as an oncogenic factor that accelerates malignant progression of Kras-mutated adenocarcinomas in the later stages of lung carcinogenesis. 
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Materials and Methods
Experimental animals
Nrf2
-/--mice with an ICR/CD-1 genetic background (outbred) were used in this study (2, 15) .
Age-matched (5~9-weeks) Nrf2
+/+ -mice were used as concurrent controls. The mice were maintained in a facility free of specific pathogens (SPF). Nude mice (8~9-weeks) were purchased from CLEA Japan. All animal experiments were performed with the approval of the Tohoku University Animal Care Committee.
Lung carcinogenesis experiments
Mouse lung tumors were induced by the intraperitoneal injection of urethane (1-g/kg body weight) (16, 17) . For the enumeration of lung surface tumors, the lungs were removed and the total number of lung surface nodules per mouse was counted macroscopically.
Kras mutation analysis
PCR-amplified DNA samples from the urethane-induced lung tumors and intact stromal tissues were subjected to sequencing analysis to detect Kras mutations. The primers amplifying the nucleotide sequences in the 2 nd exon of Kras gene, which contains codon 61, are listed in Supplementary Table S1 . 
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Microarray analysis
Surface lung tumors were excised, and surrounding tissues were carefully removed under a stereo-microscope. The lung tumors and non-tumor regions of Nrf2 +/+ -and Nrf2 -/--mice that had been treated with urethane (8 mice/group) were pooled and subjected to a whole-mouse genome microarray analysis (4×44 k; Agilent Technologies). The expression data were analyzed with GeneSpring software (Silicon Genetics). Heat maps were generated using Cluster 3.0
(http://bonsai.hgc.jp/~mdehoon/software/cluster/) and JAVA Treeview 159
(http://jtreeview.sourceforge.net/). The classification of the selected genes according to their biological and toxicological functions was performed using Ingenuity Pathway Analysis (IPA) software (Ingenuity system). P-value, represented as the negative log ratio of the IPA results, is the probability based on Fisher's exact test. The GEO accession number for the microarray data is GSE46048.
Flow cytometry
Analyses of the bone marrow (BM) cells were performed using FACS-Caliber (BD Pharmingen). Quantification of ROS level with 2,7-dichlorodihydrofluorescein diacetate (DCFDA), separation of MDSCs, and T cells has been described (9) . 
Immunoblotting analysis
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Nuclear extracts were prepared from NIH3T3 cells that were treated with the indicated concentrations of urethane for 6-h. The mouse lung nuclear extracts were prepared from the Nrf2 +/+ -mice administered either vehicle (PBS) or urethane (1-g/kg body weight) for the indicated time periods. Immunoblotting analysis was performed using anti-Nrf2 and anti-lamin B antibodies (Santa Cruz Biotechnology) as described previously (9) .
Statistical analyses
The data are expressed as the mean ± SD. The statistical differences were determined using Student's t-test or the Mann-Whitney U test. The values for either the incidence of lung nodules or large tumors were analyzed using the Fisher's exact probability test. 
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Results
Urethane induces accumulation of Nrf2 and detoxification enzymes in the lung
While urethane exerts carcinogenic activity through electrophilicity of its metabolites (18) , it remains unclear whether urethane induces Nrf2 accumulation. To address this question, we examined Nrf2 accumulation in NIH/3T3 cells treated with urethane (10 or 50 μM for 6 hours (-h)). Upon treatment with urethane, Nrf2 accumulated in nuclear fraction of NIH/3T3 cells (Fig.   1A ). We also found that Nrf2 accumulated in the lung tissues 3-h after intraperitoneal injection of urethane (1-g/kg body weight) into Nrf2 +/+ -mice (Fig. 1B) . As the Nrf2 accumulation could be monitored by the immunohistochemistry for Nrf2-β-galactosidase fusion protein expressed from the Nrf2-targeted allele (9), we conducted anti-β-galactosidase antibody staining with paraffin-embedded lung sections. The Nrf2-β-galactosidase fusion protein predominantly accumulated in the bronchial epithelium of the urethane-treated mice (arrows in Fig. 1C ). These results demonstrate that urethane induced Nrf2 accumulation in the nucleus of airway epithelial cells.
To clarify downstream events upon the urethane treatment, we next examined mRNA expression of Nrf2 target genes in the lung. Expression levels of Nrf2 target genes, i.e., Nqo1, HO-1 and Gclc, were markedly induced in the Nrf2 +/+ -mice in a time-dependent manner (Fig.   1D ). In contrast, inducible expression of the Nrf2 target genes was attenuated in the Nrf2 -/--mice.
These observations demonstrate that urethane-treatment increased the expression of Nrf2-target 
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genes through the induction of Nrf2 protein accumulation in normal lung tissue.
Cyp2e1 expression is independent of Nrf2 activity
It has been shown that Cyp2e1-mediated oxidation plays an essential role in urethane-induced carcinogenicity ( Supplementary Fig. S1A ) and indeed Cyp2e1-deficient mice are resistant to urethane-induced lung carcinogenesis (14) . To clarify whether the Nrf2-deficiency affects the urethane bioactivation to its carcinogenic metabolite, we examined the Cyp2e1 level in
Nrf2
-/--mouse lungs. Basal Cyp2e1 mRNA level did not differ substantially between Nrf2 -/--and Nrf2
+/+ -mice, and induced Cyp2e1 mRNA expression after the urethane administration was comparable between the two genotypes ( Supplementary Fig. S1B ). Cyp2e1 immunoreactivity in the airway epithelial cells was also comparable between the two genotypes regardless of the urethane treatment ( Supplementary Fig. S1C ). These results indicate that the basal and induced expression of Cyp2e1 is independent of the Nrf2 activity. We also examined mRNA expression of the enzymes involved in the detoxification process of vinyl carbamate epoxide. We found that 
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carbamate epoxide than that in Nrf2 +/+ -mice upon the urethane treatment.
Urethane elicits acute inflammatory response in Nrf2-deficient mouse lung
Nrf2
-/--mice are susceptible to a number of oxidative or electrophilic insults, including butylated hydroxytoluene and bleomycin, and the mice are more susceptible to pneumonia, fibrosis, and inflammatory cell infiltration than Nrf2
-mice (19) . Given this, we next examined inflammatory status of the lungs after the urethane treatment. We observed a large number of inflammatory cell foci in the pulmonary perivascular region of the Nrf2 -/--mice 24 -h after urethane administration, while such inflammatory cell infiltration was not observed in S2B ). Hence, we surmised that Nrf2 -/--mice were susceptible to the urethane-induced inflammatory lung injury; thereafter the inflammation-induced proliferating pulmonary epithelial cells might give rise to high frequency of lung tumorigenesis.
Nrf2 -/--mice are susceptible to urethane-induced lung carcinogenesis in early stage
To examine susceptibility to lung cancer, we adopted urethane-induced carcinogenesis (Fig. 2H ).
These results demonstrate that the Nrf2 -/--mice showed a lower susceptibility to urethane-induced carcinogenesis than the Nrf2 +/+ -mice at 16-weeks after the urethane administration.
Nrf2-deficient mice are resistant to urethane carcinogenesis at long-term observation period
An observation at even late stage revealed more significant difference in the cancer progression between Nrf2 -/--and Nrf2 +/+ -mice. At 24-weeks after the urethane administration ( Supplementary Fig. S3D ), Nrf2 -/--mice exhibited a markedly reduced number of tumors compared to the Nrf2 +/+ -mice (Fig. 3A, B and Table 1C ). In addition, the size of the tumors was larger in Nrf2 
Urethane-induced lung tumors of Nrf2 -/-mice failed to engraft in nude mice
One of the standard approaches testing the tumorigenicity of cancer cells is to transplant the cells into immuno-deficiency mice (22) . When highly metastatic 3LL cells were transplanted into Nrf2 -/--mice, Nrf2-deficiency generated a more permissive microenvironment for cancer cell growth than that in Nrf2 +/+ -mice (9). We therefore hypothesized that the less proliferative Nrf2-deficient tumor cells might be able to grow in a tumor-permissive microenvironment in the Fig. 3G and 3H ). These results demonstrate that Nrf2 -/--tumor cells suffer from a cell-autonomous growth defect.
Nrf2-deficiency decreased the malignancy-risk gene signature
To clarify whether Nrf2 is functionally activated in urethane-induced tumors, we examined expression of glutathione peroxide (Gpx2) and multidrug resistance-associated protein 4 (Mrp4) mRNAs, as both Gpx2 and Mrp4 contribute to the promotion of cancer (23, 24) . The Of the 114 genes increased in the lung tumor tissues, 57 genes were increased solely in the 
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Nrf2
+/+ -tumors and 25 genes were increased solely in the Nrf2 -/--tumors, while 32 genes were increased in both tumor genotypes ( Fig. 4B and C 
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cancer progression ( Supplementary Fig. S4A and B) .
Low frequency of constitutively active Kras mutations in Nrf2-deficient mice
Kras mutations are strongly associated with the progression of adenocarcinomas (29, 31) and Kras activation induces Nrf2 mRNA expression to exert its oncogenic activity as summarized 
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clinical prognosis of the patients (34) . Spp1-deficient mice are resistant to chemically induced skin tumorigenesis, suggesting the oncogenic function of Spp1 (35) . We found that Spp1 expression was 2.5-fold higher in Nrf2 -/--tumors than in Nrf2 +/+ -tumors (Fig. 4D) . A microarray analysis revealed that a number of other lung cancer-related genes, such as Grin2A (36) , Itgav (37), and Ptk6 (38), were preferentially induced in the Nrf2 -/--tumors. These data suggest that the Nrf2 -/--cancer cells develop through Kras-independent oncogenic pathways. 
Nrf2-deficient cancers show reduced potency for activation of MDSCs
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increased MDSCs-ROS levels compared with the concurrently vehicle-treated mice (Fig. 6A) .
However, the MDSCs-ROS levels in the tumor-bearing Nrf2 -/--mice were only slightly increased relative to the vehicle-treated mice.
Consistent with the increase of MDSCs-ROS levels, the number of splenic CD8
+ -T-cells was markedly decreased in the tumor-bearing Nrf2
+/+ -mice ( Fig. 6C and E) . In contrast, the 
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Discussion
In this study we have demonstrated that Nrf2 -/--mice are sensitive to chemical carcinogens and exhibit a high-level of cancer initiation in the early stages of urethane-induced lung carcinogenesis. In stark contrast, in the late stages of the urethane carcinogenesis the Nrf2 -/--mice developed much less malignant cancers than the control Nrf2 +/+ -mice did. These results indicate that the Nrf2 activity accelerates the malignant transformation of benign adenoma to adenocarcinoma. Molecular basis of the Nrf2 contribution to the urethane carcinogenesis is summarized in Supplementary Fig. S5 .
The constitutively active Kras mutations have been identified in many types of human cancers, including lung, pancreas and colon, as well as in experimental cancer models of rodents (42) . Urethane is known to cause Kras codon 61 mutations in multiple mouse strains (33) . An important observation is that Kras activates Nrf2 and leads to the cancer malignant transformation (32) . Therefore, in the Nrf2 -/--mice, even if lung cells suffer a large number of initial genetic hits by the urethane metabolites, subsequent progression of malignant transformation is markedly attenuated because of the lack of Nrf2 activity.
In contrast, several chemical carcinogens are known to rarely induce activating Kras mutations. Such carcinogens include N-nitrosobutyl (4-hydroxybutyl) amine, azoxymethane, and 7,12-dimethyl-benz[a]anthracene. Of note is that these carcinogens are found to provoke cancers more abundantly in the Nrf2 -/--mice than Nrf2 +/+ -mice (3, 6, 43) . We surmise that 
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these Kras-independent carcinogens evoke a higher number of cancers in the Nrf2 -/--mice as a direct consequence of the increased chemical susceptibility and activation of other oncogenic pathways.
Spp1, an integrin-binding and cell transformation-related protein, highly associates with the malignancy of non-small cell lung carcinoma (34) . We found that Spp1 is much more 
